160 related articles for article (PubMed ID: 24866187)
41. Loss of p27Kip1 from cyclin E/cyclin-dependent kinase (CDK) 2 but not from cyclin D1/CDK4 complexes in cells transformed by polyamine biosynthetic enzymes.
Ravanko K; Järvinen K; Paasinen-Sohns A; Hölttä E
Cancer Res; 2000 Sep; 60(18):5244-53. PubMed ID: 11016654
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway.
Diehl JA; Zindy F; Sherr CJ
Genes Dev; 1997 Apr; 11(8):957-72. PubMed ID: 9136925
[TBL] [Abstract][Full Text] [Related]
43. S-Phase entry upon ectopic expression of G1 cyclin-dependent kinases in the absence of retinoblastoma protein phosphorylation.
Leng X; Connell-Crowley L; Goodrich D; Harper JW
Curr Biol; 1997 Sep; 7(9):709-12. PubMed ID: 9285720
[TBL] [Abstract][Full Text] [Related]
44. Potassium-induced apoptosis in rat cerebellar granule cells involves cell-cycle blockade at the G1/S transition.
Martín-Romero FJ; Santiago-Josefat B; Correa-Bordes J; Gutierrez-Merino C; Fernandez-Salguero P
J Mol Neurosci; 2000 Dec; 15(3):155-65. PubMed ID: 11303780
[TBL] [Abstract][Full Text] [Related]
45. DDA1, a novel oncogene, promotes lung cancer progression through regulation of cell cycle.
Cheng L; Yang Q; Li C; Dai L; Yang Y; Wang Q; Ding Y; Zhang J; Liu L; Zhang S; Fan P; Hu X; Xiang R; Yu D; Wei Y; Deng H
J Cell Mol Med; 2017 Aug; 21(8):1532-1544. PubMed ID: 28211159
[TBL] [Abstract][Full Text] [Related]
46. Cyclin D1 promotes cell cycle progression through enhancing NDR1/2 kinase activity independent of cyclin-dependent kinase 4.
Du Z; Tong X; Ye X
J Biol Chem; 2013 Sep; 288(37):26678-87. PubMed ID: 23897809
[TBL] [Abstract][Full Text] [Related]
47. Estrogen regulation of cyclin E2 requires cyclin D1 but not c-Myc.
Caldon CE; Sergio CM; Schütte J; Boersma MN; Sutherland RL; Carroll JS; Musgrove EA
Mol Cell Biol; 2009 Sep; 29(17):4623-39. PubMed ID: 19564413
[TBL] [Abstract][Full Text] [Related]
48. Immortalization of human fibroblasts by SV40 large T antigen results in the reduction of cyclin D1 expression and subunit association with proliferating cell nuclear antigen and Waf1.
Peterson SR; Gadbois DM; Bradbury EM; Kraemer PM
Cancer Res; 1995 Oct; 55(20):4651-7. PubMed ID: 7553644
[TBL] [Abstract][Full Text] [Related]
49. Overview of cyclins D1 function in cancer and the CDK inhibitor landscape: past and present.
Casimiro MC; Velasco-Velázquez M; Aguirre-Alvarado C; Pestell RG
Expert Opin Investig Drugs; 2014 Mar; 23(3):295-304. PubMed ID: 24387133
[TBL] [Abstract][Full Text] [Related]
50. Requirement for Ras/Raf/ERK pathway in naringin-induced G1-cell-cycle arrest via p21WAF1 expression.
Kim DI; Lee SJ; Lee SB; Park K; Kim WJ; Moon SK
Carcinogenesis; 2008 Sep; 29(9):1701-9. PubMed ID: 18296682
[TBL] [Abstract][Full Text] [Related]
51. Thyroid hormone-induced cell proliferation in GC cells is mediated by changes in G1 cyclin/cyclin-dependent kinase levels and activity.
Barrera-Hernandez G; Park KS; Dace A; Zhan Q; Cheng SY
Endocrinology; 1999 Nov; 140(11):5267-74. PubMed ID: 10537157
[TBL] [Abstract][Full Text] [Related]
52. Downregulation of cyclin D1 alters cdk 4- and cdk 2-specific phosphorylation of retinoblastoma protein.
Yu B; Lane ME; Pestell RG; Albanese C; Wadler S
Mol Cell Biol Res Commun; 2000 Jun; 3(6):352-9. PubMed ID: 11032757
[TBL] [Abstract][Full Text] [Related]
53. Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1.
Aktas H; Cai H; Cooper GM
Mol Cell Biol; 1997 Jul; 17(7):3850-7. PubMed ID: 9199319
[TBL] [Abstract][Full Text] [Related]
54. The cancer/testis antigen CAGE with oncogenic potential stimulates cell proliferation by up-regulating cyclins D1 and E in an AP-1- and E2F-dependent manner.
Por E; Byun HJ; Lee EJ; Lim JH; Jung SY; Park I; Kim YM; Jeoung DI; Lee H
J Biol Chem; 2010 May; 285(19):14475-85. PubMed ID: 20220142
[TBL] [Abstract][Full Text] [Related]
55. Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells.
Doisneau-Sixou SF; Sergio CM; Carroll JS; Hui R; Musgrove EA; Sutherland RL
Endocr Relat Cancer; 2003 Jun; 10(2):179-86. PubMed ID: 12790780
[TBL] [Abstract][Full Text] [Related]
56. Molecular mechanisms orchestrating cyclin stability.
Gong Y; Chan TA
Cell Cycle; 2014; 13(16):2487-8. PubMed ID: 25486187
[No Abstract] [Full Text] [Related]
57. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells.
Arber N; Doki Y; Han EK; Sgambato A; Zhou P; Kim NH; Delohery T; Klein MG; Holt PR; Weinstein IB
Cancer Res; 1997 Apr; 57(8):1569-74. PubMed ID: 9108461
[TBL] [Abstract][Full Text] [Related]
58. Apogossypolone inhibits cell growth by inducing cell cycle arrest in U937 cells.
Sun J; Li ZM; Hu ZY; Zeng ZL; Yang DJ; Jiang WQ
Oncol Rep; 2009 Jul; 22(1):193-8. PubMed ID: 19513523
[TBL] [Abstract][Full Text] [Related]
59. Cell cycle progression without cyclin E/CDK2: breaking down the walls of dogma.
Gladden AB; Diehl JA
Cancer Cell; 2003 Sep; 4(3):160-2. PubMed ID: 14522248
[TBL] [Abstract][Full Text] [Related]
60. Ectopic expression of cyclin D1 but not cyclin E induces anchorage-independent cell cycle progression.
Resnitzky D
Mol Cell Biol; 1997 Sep; 17(9):5640-7. PubMed ID: 9271439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
